Abstract
Recent studies have suggested that regulatory T (Treg) cells comprise a heterogeneous population that regulates various aspects of the immune response, and that Treg cells use the factors that are expressed in their target cells to regulate them. We searched for factors that regulate Th1 response in Treg cells using a meta-analysis. In the process, we discovered that transcription factor interferon regulatory factor 8 (IRF8) was selectively expressed in Treg and Th1 cells. IRF8-deficient Treg cells showed defective expression of CXCR3 and aberrant expression of the Il4 and Il17 genes. Upon treatment with alpha galactosyl-C18-ceramide (αGal-C18-Cer), IRF8-deficient mice showed defective Treg cell recruitment in the liver. Eliciting Th1 immune response by anti-CD40 antibody injection in mice induced IRF8 expression in Treg cells. The expression of IRF8 was induced by Foxp3 in Treg cells. IRF8 had no effect on T-bet expression in Treg and vice versa. Thus, our results strongly suggest that IRF8 controls Th1 immune response in Treg cells independent of T-bet.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Josefowicz SZ, Lu LF, Rudensky AY . Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30: 531–564.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M . Regulatory T cells and immune tolerance. Cell 2008; 133: 775–787.
Campbell DJ, Koch MA . Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 2011; 11: 119–130.
Hall BM, Verma ND, Tran GT, Hodgkinson SJ . Distinct regulatory CD4+T cell subsets; differences between naive and antigen specific T regulatory cells. Curr Opin Immunol 2011; 23: 641–647.
Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ . The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10: 595–602.
Ferlin WG, von der Weid T, Cottrez F, Ferrick DA, Coffman RL, Howard MC . The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur J Immunol 1998; 28: 525–531.
Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009; 458: 351–356.
Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326: 986–991.
Chung Y, Tanaka S, Chu F, Nurieva RI, Martinez GJ, Rawal S et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med 2011; 17: 983–988.
Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med 2011; 17: 975–982.
Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F et al. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996; 87: 307–317.
Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG . Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 2009; 49: 1267–1276.
Jacysyn JF, Abrahamsohn IA, Macedo MS . Modulation of delayed-type hypersensitivity during the time course of immune response to a protein antigen. Immunology 2001; 102: 373–379.
Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009; 30: 155–167.
Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 1998; 187: 2009–2021.
Farber JM . A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 1990; 87: 5238–5242.
Luster AD, Unkeless JC, Ravetch JV . Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 1985; 315: 672–676.
Miyagawa F, Zhang H, Terunuma A, Ozato K, Tagaya Y, Katz SI . Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells. Proc Natl Acad Sci USA 2012; 109: 12123–12128.
Fu W, Ergun A, Lu T, Hill JA, Haxhinasto S, Fassett MS et al. A multiply redundant genetic switch ‘locks in’ the transcriptional signature of regulatory T cells. Nat Immunol 2012; 13: 972–980.
Tamura T, Yanai H, Savitsky D, Taniguchi T . The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 2008; 26: 535–584.
Savitsky D, Tamura T, Yanai H, Taniguchi T . Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol Immunother 2010; 59: 489–510.
Battistini A . Interferon regulatory factors in hematopoietic cell differentiation and immune regulation. J Interferon Cytokine Res 2009; 29: 765–780.
Tamura T, Nagamura-Inoue T, Shmeltzer Z, Kuwata T, Ozato K . ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 2000; 13: 155–165.
Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC, 3rd et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells. J Exp Med 2002; 196: 1415–1425.
Tsujimura H, Tamura T, Gongora C, Aliberti J, Reis e Sousa C, Sher A et al. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood 2003; 101: 961–969.
Tamura T, Tailor P, Yamaoka K, Kong HJ, Tsujimura H, O’Shea JJ et al. IFN regulatory factor-4 and -8 govern dendritic cell subset development and their functional diversity. J Immunol 2005; 174: 2573–2581.
Lu R, Medina KL, Lancki DW, Singh H . IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev 2003; 17: 1703–1708.
Milanovic M, Terszowski G, Struck D, Liesenfeld O, Carstanjen D . IFN consensus sequence binding protein (Icsbp) is critical for eosinophil development. J Immunol 2008; 181: 5045–5053.
Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K . Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J Exp Med 1997; 186: 1523–1534.
Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, Contursi C et al. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J Exp Med 1997; 186: 1535–1546.
Ouyang X, Zhang R, Yang J, Li Q, Qin L, Zhu C et al. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat Commun 2011; 2: 314.
Grindebacke H, Stenstad H, Quiding-Jarbrink M, Waldenstrom J, Adlerberth I, Wold AE et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol 2009; 183: 4360–4370.
Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 2012; 37: 511–523.
Hasegawa H, Inoue A, Kohno M, Lei J, Miyazaki T, Yoshie O et al. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther 2008; 15: 171–182.
Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K et al. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res 2012; 72: 4351–4360.
Acknowledgements
We thank Drs. Keiko Ozato (National Institutes of Health) and Tomohiko Tamura (Yokohama City University) for providing and transferring IRF8-deficient mice, respectively. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (NRF-2010-0017447 and NRF-2014R1A2A1A11052545).
Author information
Authors and Affiliations
Additional information
Supplementary Information of this article can be found on Cellular & Molecular Immunology website: http://www.nature.com/cmi.
Supplementary information
Rights and permissions
About this article
Cite this article
Lee, W., Kim, H., Baek, S. et al. Transcription factor IRF8 controls Th1-like regulatory T-cell function. Cell Mol Immunol 13, 785–794 (2016). https://doi.org/10.1038/cmi.2015.72
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2015.72
Keywords
This article is cited by
-
Treg plasticity and human diseases
Inflammation Research (2023)
-
USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
Cancer Cell International (2020)
-
Regulatory T Cell Plasticity and Stability and Autoimmune Diseases
Clinical Reviews in Allergy & Immunology (2020)
-
Ankylosing spondylitis is associated with aberrant DNA methylation of IFN regulatory factor 8 gene promoter region
Clinical Rheumatology (2019)
-
Insights on the crosstalk between dendritic cells and helper T cells in novel genetic etiology for mendelian susceptible mycobacterial disease
Cellular & Molecular Immunology (2018)